BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

849 related articles for article (PubMed ID: 33412233)

  • 1. Are extracellular vesicles new hope in clinical drug delivery for neurological disorders?
    Muhammad SA
    Neurochem Int; 2021 Mar; 144():104955. PubMed ID: 33412233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extracellular Vesicles as Drug Delivery Vehicles to the Central Nervous System.
    Shahjin F; Chand S; Yelamanchili SV
    J Neuroimmune Pharmacol; 2020 Sep; 15(3):443-458. PubMed ID: 31485884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extracellular vesicles: Novel promising delivery systems for therapy of brain diseases.
    Rufino-Ramos D; Albuquerque PR; Carmona V; Perfeito R; Nobre RJ; Pereira de Almeida L
    J Control Release; 2017 Sep; 262():247-258. PubMed ID: 28687495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extracellular vesicles for drug delivery.
    Vader P; Mol EA; Pasterkamp G; Schiffelers RM
    Adv Drug Deliv Rev; 2016 Nov; 106(Pt A):148-156. PubMed ID: 26928656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exosomes as drug delivery vehicles and biomarkers for neurological and auditory systems.
    Mittal R; Bencie N; Langlie J; Mittal J; Eshraghi AA
    J Cell Physiol; 2021 Dec; 236(12):8035-8049. PubMed ID: 34224589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extracellular Vesicles in the Treatment of Parkinson's Disease: A Review.
    Yang X; Ma Y; Xie H; Dong S; Rao G; Yang Z; Zhang J; Wu Q
    Curr Med Chem; 2021; 28(31):6375-6394. PubMed ID: 33441061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methods and Protocols for Using Extracellular Vesicles as Delivery Vehicles in Neuronal Research.
    Vaidya M; Sayeed N; Hobson C; Sreerama S; Smith J; Shah R; Sugaya K
    Methods Mol Biol; 2023; 2668():159-189. PubMed ID: 37140797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor-Derived Extracellular Vesicles Breach the Intact Blood-Brain Barrier
    Morad G; Carman CV; Hagedorn EJ; Perlin JR; Zon LI; Mustafaoglu N; Park TE; Ingber DE; Daisy CC; Moses MA
    ACS Nano; 2019 Dec; 13(12):13853-13865. PubMed ID: 31479239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extracellular Vesicles - Advanced Nanocarriers in Cancer Therapy: Progress and Achievements.
    Huyan T; Li H; Peng H; Chen J; Yang R; Zhang W; Li Q
    Int J Nanomedicine; 2020; 15():6485-6502. PubMed ID: 32922012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent progress of drug nanoformulations targeting to brain.
    Khan AR; Yang X; Fu M; Zhai G
    J Control Release; 2018 Dec; 291():37-64. PubMed ID: 30308256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Transport Mechanism of Extracellular Vesicles at the Blood-Brain Barrier.
    Matsumoto J; Stewart T; Banks WA; Zhang J
    Curr Pharm Des; 2017; 23(40):6206-6214. PubMed ID: 28914201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strategies for the use of Extracellular Vesicles for the Delivery of Therapeutics.
    Sil S; Dagur RS; Liao K; Peeples ES; Hu G; Periyasamy P; Buch S
    J Neuroimmune Pharmacol; 2020 Sep; 15(3):422-442. PubMed ID: 31456107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Membrane Derived Vesicles as Biomimetic Carriers for Targeted Drug Delivery System.
    Zhang LY; Yang X; Wang SB; Chen H; Pan HY; Hu ZM
    Curr Top Med Chem; 2020; 20(27):2472-2492. PubMed ID: 32962615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic potential of extracellular vesicles in neurodegenerative disorders.
    Roudi S; Rädler JA; El Andaloussi S
    Handb Clin Neurol; 2023; 193():243-266. PubMed ID: 36803815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stem Cell-derived Extracellular Vesicles: A Promising Nano Delivery Platform to the Brain?
    Guo Y; Hu D; Lian L; Zhao L; Li M; Bao H; Xu S
    Stem Cell Rev Rep; 2023 Feb; 19(2):285-308. PubMed ID: 36173500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extracellular Vesicles as Innovative Tool for Diagnosis, Regeneration and Protection against Neurological Damage.
    Andjus P; Kosanović M; Milićević K; Gautam M; Vainio SJ; Jagečić D; Kozlova EN; Pivoriūnas A; Chachques JC; Sakaj M; Brunello G; Mitrecic D; Zavan B
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32962107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extracellular Vesicles as Biological Shuttles for Targeted Therapies.
    Raimondo S; Giavaresi G; Lorico A; Alessandro R
    Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 30991632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting and Crossing the Blood-Brain Barrier with Extracellular Vesicles.
    Saint-Pol J; Gosselet F; Duban-Deweer S; Pottiez G; Karamanos Y
    Cells; 2020 Apr; 9(4):. PubMed ID: 32244730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extracellular vesicles as drug delivery systems: lessons from the liposome field.
    van der Meel R; Fens MH; Vader P; van Solinge WW; Eniola-Adefeso O; Schiffelers RM
    J Control Release; 2014 Dec; 195():72-85. PubMed ID: 25094032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extracellular vesicles as drug delivery systems: Why and how?
    Elsharkasy OM; Nordin JZ; Hagey DW; de Jong OG; Schiffelers RM; Andaloussi SE; Vader P
    Adv Drug Deliv Rev; 2020; 159():332-343. PubMed ID: 32305351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.